Logo image of NYXH.BR

NYXOAH SA (NYXH.BR) Stock Price, Forecast & Analysis

Europe - EBR:NYXH - BE0974358906 - Common Stock

4.34 EUR
+0.01 (+0.23%)
Last: 11/6/2025, 7:00:00 PM

NYXH.BR Key Statistics, Chart & Performance

Key Statistics
Market Cap162.45M
Revenue(TTM)4.93M
Net Income(TTM)-77.20M
Shares37.43M
Float21.81M
52 Week High11.15
52 Week Low3.84
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.11
PEN/A
Fwd PEN/A
Earnings (Next)11-13 2025-11-13
IPO2020-09-18
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


NYXH.BR short term performance overview.The bars show the price performance of NYXH.BR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

NYXH.BR long term performance overview.The bars show the price performance of NYXH.BR in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of NYXH.BR is 4.34 EUR. In the past month the price decreased by -22.78%. In the past year, price decreased by -50.46%.

NYXOAH SA / NYXH Daily stock chart

NYXH.BR Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
2M6.DE MEDTRONIC PLC16.28100.05B
SHL.DE SIEMENS HEALTHINEERS AG18.5549.80B
PHIA.AS KONINKLIJKE PHILIPS NV16.8823.41B
PHI1.DE KONINKLIJKE PHILIPS NV16.9623.51B
BIM.PA BIOMERIEUX27.7212.66B
AFX.DE CARL ZEISS MEDITEC AG - BR24.573.76B
DIA.MI DIASORIN SPA17.183.34B
DRW3.DE DRAEGERWERK AG - PREF10.361.25B
DRW8.DE DRAEGERWERK AG9.121.10B
EUZ.DE ECKERT & ZIEGLER SE26.921.01B
ELN.MI EL.EN. SPA16.95870.50M
GVS.MI GVS SPA46.44790.77M

About NYXH.BR

Company Profile

NYXH logo image Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 184 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

Company Info

NYXOAH SA

Rue Edouard Belin 12

Mont-Saint-Guibert BRABANT-WALLON BE

Employees: 184

NYXH Company Website

NYXH Investor Relations

Phone: 3226121755

NYXOAH SA / NYXH.BR FAQ

What does NYXH do?

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 184 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.


What is the current price of NYXH stock?

The current stock price of NYXH.BR is 4.34 EUR. The price increased by 0.23% in the last trading session.


What is the dividend status of NYXOAH SA?

NYXH.BR does not pay a dividend.


What is the ChartMill rating of NYXOAH SA stock?

NYXH.BR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


How many employees does NYXOAH SA have?

NYXOAH SA (NYXH.BR) currently has 184 employees.


Can you provide the market cap for NYXOAH SA?

NYXOAH SA (NYXH.BR) has a market capitalization of 162.45M EUR. This makes NYXH.BR a Micro Cap stock.


What is the next earnings date for NYXH stock?

NYXOAH SA (NYXH.BR) will report earnings on 2025-11-13.


NYXH.BR Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

NYXH.BR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to NYXH.BR. While NYXH.BR seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NYXH.BR Financial Highlights

Over the last trailing twelve months NYXH.BR reported a non-GAAP Earnings per Share(EPS) of -2.11. The EPS decreased by -41.57% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -66.28%
ROE -105.18%
Debt/Equity 0.29
Chartmill High Growth Momentum
EPS Q2Q%-28.74%
Sales Q2Q%73.8%
EPS 1Y (TTM)-41.57%
Revenue 1Y (TTM)2.94%

NYXH.BR Forecast & Estimates

14 analysts have analysed NYXH.BR and the average price target is 12.19 EUR. This implies a price increase of 180.85% is expected in the next year compared to the current price of 4.34.

For the next year, analysts expect an EPS growth of -18.11% and a revenue growth 57.01% for NYXH.BR


Analysts
Analysts81.43
Price Target12.19 (180.88%)
EPS Next Y-18.11%
Revenue Next Year57.01%

NYXH.BR Ownership

Ownership
Inst Owners22.74%
Ins Owners22.07%
Short Float %N/A
Short RatioN/A